UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of S53P4 Bioactive Glass for the Secondary Obliteration of Chronically Discharging Radical Cavities

OTO open : the official open access journal of the American Academy of Otolaryngology--Head and Neck Surgery Foundation, 2023-10, Vol.7 (4), p.e96-n/a

2023

Volltextzugriff (PDF)

18F-NaF PET/CT imaging of bone formation induced by bioactive glass S53P4 after mastoid obliteration

European journal of hybrid imaging, 2019-10, Vol.3 (1), p.1-7, Article 18

2019

Volltextzugriff (PDF)

Mastoid Obliteration Using S53P4 Bioactive Glass in Cholesteatoma Surgery: A 10-Year Single-Center Experience in 173 Adult Patients with Long-Term Magnetic Resonance Imaging Controlled Follow-up

Otology & neurotology, 2022-12, Vol.43 (10), p.1181-1188

2022

Volltextzugriff (PDF)

Cholesteatoma surgery in the pediatric population: remaining challenges in the era of mastoid obliteration

European archives of oto-rhino-laryngology, 2023-04, Vol.280 (4), p.1713-1722

2023

Volltextzugriff (PDF)

Mastoid obliteration with S53P4 bioactive glass in cholesteatoma surgery

Acta oto-laryngologica, 2017-07, Vol.137 (7), p.690-694

2017

Volltextzugriff (PDF)

Clinical Significance of Micrometastatic Cells Detected by E48 (Ly-6D) Reverse Transcription-Polymerase Chain Reaction in Bone Marrow of Head and Neck Cancer Patients

Clinical cancer research, 2004-12, Vol.10 (23), p.7827-7833

2004

Volltextzugriff (PDF)

In response to letter to the editor: Lyme disease associated with sudden sensorineural hearing loss: case report and literature review

Otology & neurotology, 2013-10, Vol.34 (8), p.1544

2013

Volltextzugriff (PDF)

Lyme disease associated with sudden sensorineural hearing loss: case report and literature review

Otology & neurotology, 2013-07, Vol.34 (5), p.832-837

2013

Volltextzugriff (PDF)

Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma

Clinical cancer research, 2003-09, Vol.9 (10 Pt 2), p.3961S

2003

Volltextzugriff (PDF)

Head and neck squamous cell carcinoma: US-guided fine-needle aspiration of sentinel lymph nodes for improved staging--initial experience

Radiology, 2001-01, Vol.218 (1), p.289-293

2001

Volltextzugriff (PDF)

In Reponse to Letter to the Editor: Lyme Disease Associated With Sudden Sensorineural Hearing Loss Case Report and Literature Review

Otology & neurotology, 2013-10, Vol.34 (8), p.1544

2013

Volltextzugriff (PDF)

Postoperative Patient Reported Outcomes After Cholesteatoma Surgery

Otology & neurotology, 2022-06, Vol.43 (5), p.e582-e589

2022

Volltextzugriff (PDF)

Practical applicability of the STAMCO and ChOLE classification in cholesteatoma care

European archives of oto-rhino-laryngology, 2021-10, Vol.278 (10), p.3777-3787

2021

Volltextzugriff (PDF)

Radioimmunotherapy in patients with head and neck squamous cell carcinoma: Initial experience

Head & neck, 2001-07, Vol.23 (7), p.559-565

2001

Volltextzugriff (PDF)

Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck

Cancer Immunology, Immunotherapy : CII, 2003-09, Vol.52 (9), p.576-582

2003

Volltextzugriff (PDF)

Reinfusion of Unprocessed, Granulocyte Colony-stimulating Factor-stimulated Whole Blood Allows Dose Escalation of 186Relabeled Chimeric Monoclonal Antibody U36 Radioimmunotherapy in a Phase I Dose Escalation Study

Clinical cancer research, 2002-11, Vol.8 (11), p.3401-3406

2002

Volltextzugriff (PDF)

Phase I therapy study of (186)re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck

The Journal of nuclear medicine (1978), 2000-12, Vol.41 (12), p.1999

2000

Volltextzugriff (PDF)

Evaluation of limited bone sampling in a preceding (99m)Tc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of (186)Re-cMAb U36 radioimmunotherapy

The Journal of nuclear medicine (1978), 2001-09, Vol.42 (9), p.1364

2001

Volltextzugriff (PDF)

Phase I Therapy Study with 186Re-labeled Humanized Monoclonal Antibody BIWA 4 (Bivatuzumab) in Patients with Head and Neck Squamous Cell Carcinoma

Clinical cancer research, 2003-09, Vol.9 (10), p.3961s

2003

Volltextzugriff (PDF)

Safety, biodistribution, pharmacokinetics, and immunogenicity of 99m Tc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck

Cancer Immunology, Immunotherapy, 2003-09, Vol.52 (9), p.576-582

2003

Volltextzugriff (PDF)

Evaluation of Limited Blood Sampling in a Preceding 99mTc-Labeled Diagnostic Study to Predict the Pharmacokinetics and Myelotoxicity of 186Re-cMAb U36 Radioimmunotherapy

The Journal of nuclear medicine (1978), 2001-09, Vol.42 (9), p.1364-1367

2001

Volltextzugriff (PDF)

Phase I Therapy Study of 186Re-Labeled Chimeric Monoclonal Antibody U36 in Patients with Squamous Cell Carcinoma of the Head and Neck

The Journal of nuclear medicine (1978), 2000-12, Vol.41 (12), p.1999

2000

Volltextzugriff (PDF)

Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck. Commentary

The Journal of nuclear medicine (1978), 2000, Vol.41 (12), p.1999-2014

2000

Volltextzugriff (PDF)

Hypoxaemia and bradycardia in children during guillotine adenotonsillectomy without intubation

Nederlands tijdschrift voor geneeskunde, 2010, Vol.154, p.A1889

2010

Volltextzugriff (PDF)

Experimental Research Methods in Orthopedics and Trauma

Hamish Simpson, Peter Augat

1, 2021

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(24)
Bücher
(2)

Sprache

Englisch
(24)
Niederländisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(16)
Female
(12)
Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Male
(10)
Otorhinolaryngology
(10)
Middle Aged
(9)
Aged
(8)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Retrospective Studies
(7)
Adult
(6)
Treatment Outcome
(6)
Cholesteatoma
(5)
Cholesteatoma, Middle Ear - Surgery
(5)
Radioisotopes - Therapeutic Use
(5)
Rhenium - Therapeutic Use
(5)
S53p4
(5)
Surgery
(5)
Antibodies, Monoclonal - Pharmacokinetics
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of S53P4 Bioactive Glass for the Secondary Obliteration of Chronically Discharging Radical Cavities

18F-NaF PET/CT imaging of bone formation induced by bioactive glass S53P4 after mastoid obliteration

Mastoid Obliteration Using S53P4 Bioactive Glass in Cholesteatoma Surgery: A 10-Year Single-Center Experience in 173 Adult Patients with Long-Term Magnetic Resonance Imaging Controlled Follow-up

Cholesteatoma surgery in the pediatric population: remaining challenges in the era of mastoid obliteration

Mastoid obliteration with S53P4 bioactive glass in cholesteatoma surgery

Clinical Significance of Micrometastatic Cells Detected by E48 (Ly-6D) Reverse Transcription-Polymerase Chain Reaction in Bone Marrow of Head and Neck Cancer Patients

In response to letter to the editor: Lyme disease associated with sudden sensorineural hearing loss: case report and literature review

Lyme disease associated with sudden sensorineural hearing loss: case report and literature review

Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma: US-guided fine-needle aspiration of sentinel lymph nodes for improved staging--initial experience

In Reponse to Letter to the Editor: Lyme Disease Associated With Sudden Sensorineural Hearing Loss Case Report and Literature Review

Postoperative Patient Reported Outcomes After Cholesteatoma Surgery

Practical applicability of the STAMCO and ChOLE classification in cholesteatoma care

Radioimmunotherapy in patients with head and neck squamous cell carcinoma: Initial experience

Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck

Reinfusion of Unprocessed, Granulocyte Colony-stimulating Factor-stimulated Whole Blood Allows Dose Escalation of 186Relabeled Chimeric Monoclonal Antibody U36 Radioimmunotherapy in a Phase I Dose Escalation Study

Phase I therapy study of (186)re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck

Evaluation of limited bone sampling in a preceding (99m)Tc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of (186)Re-cMAb U36 radioimmunotherapy

Phase I Therapy Study with 186Re-labeled Humanized Monoclonal Antibody BIWA 4 (Bivatuzumab) in Patients with Head and Neck Squamous Cell Carcinoma

Safety, biodistribution, pharmacokinetics, and immunogenicity of 99m Tc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck

Evaluation of Limited Blood Sampling in a Preceding 99mTc-Labeled Diagnostic Study to Predict the Pharmacokinetics and Myelotoxicity of 186Re-cMAb U36 Radioimmunotherapy

Phase I Therapy Study of 186Re-Labeled Chimeric Monoclonal Antibody U36 in Patients with Squamous Cell Carcinoma of the Head and Neck

Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck. Commentary

Hypoxaemia and bradycardia in children during guillotine adenotonsillectomy without intubation

Experimental Research Methods in Orthopedics and Trauma

Suchergebnisse filtern